# Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification

> **NCT02799173** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 74 (actual)

## Conditions studied

- Osteoporosis
- Lupus Erythematosus, Systemic

## Interventions

- **BIOLOGICAL:** RANKL/OPG ratio
- **DEVICE:** bone densitometry
- **DEVICE:** fan beam CT scan
- **DEVICE:** Doppler ultrasound

## Key facts

- **NCT ID:** NCT02799173
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-15
- **Primary completion:** 2015-07-01
- **Final completion:** 2015-07-01
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799173, "Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02799173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*